Expansion of Pharmaceutical Firm in Philadelphia to Create Over 150 Jobs
09/07/2011
The move should be complete by fourth quarter 2012. Currently the firm takes up 19,000-sq.-ft. of space at the corporate facility.
Founded in 2006, Iroko specializes in nanoformulation technology used to to create improved versions of existing nonsteroidal, anti-inflammatory drugs.
Iroko President/CEO John Vavricka said his company needs the additional room to prepare for the anticipated launch of a new drug product, slated for 2013. "We've run out of space," he said. "Launching a product in the United States is going to require a much larger footprint."
Iroko was initially drawn to the location due to the numerous advantages Philadelphia offers life sciences businesses, such as its "highly educated workforce and research infrastructure," said a company official.
Project Announcements
Jel Sert Company Expands West Chicago, Illinois, Manufacturing Operations
06/16/2025
Technomics Expands Arlington County, Virginia, Operations
06/16/2025
Conveyor Technology Expands North Little Rock, Arkansas, Manufacturing Operations
06/16/2025
Amazon Plans Salem Township-Falls Township, Pennsylvania, Operations
06/16/2025
Sentio BioSciences Expands Maryland Heights, Missouri, Production Operations
06/14/2025
Titan Mechanical Plans Defiance, Ohio, Fabrication Operations
06/12/2025
Most Read
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Get Your Mega Site ‘Project Ready’
Q2 2025
-
Navigating the new era of SCIF construction
Q1 2025
-
Why Cold Storage May Defy the Tariff Crunch
Q2 2025